UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 269

Sortiert nach

A real‐world study focused on the long‐term efficacy of mycophenolate mofetil as first‐line treatment of autoimmune hepatitis

Alimentary pharmacology & therapeutics, 2016-05, Vol.43 (10), p.1035-1047

2016

Volltextzugriff (PDF)

Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis

Gut, 2005-04, Vol.54 (4), p.528-532

2005

Volltextzugriff (PDF)

Infectomics and autoinfectomics: a tool to study infectious-induced autoimmunity

Lupus, 2015-04, Vol.24 (4-5), p.364-373

2015

Volltextzugriff (PDF)

DARING-B: discontinuation of effective entecavir or tenofovir therapy in non-cirrhotic HBeAg-negative chronic hepatitis B patients: a prospective Greek study

Journal of hepatology, 2017, Vol.66 (1), p.S26-S26

2017

Volltextzugriff (PDF)

Blocking of interleukin-10 receptor—a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus

Clinical Immunology, 2005-10, Vol.117 (1), p.57-64

2005

Volltextzugriff (PDF)

Peculiar antibody reactivity to human connexin 37 and its microbial mimics in patients with Crohn's disease

Journal of Crohn's and colitis, 2011-04, Vol.5 (2), p.101-109

2011

Volltextzugriff (PDF)

Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection

Digestive and liver disease, 2003-11, Vol.35 (11), p.801-805

2003

Volltextzugriff (PDF)

Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients

Journal of clinical virology, 2003-08, Vol.27 (3), p.213-230

2003

Volltextzugriff (PDF)

Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus

Antiviral research, 2007-07, Vol.75 (1), p.36-42

2007

Volltextzugriff (PDF)

Familial primary biliary cirrhosis: Like mother, like daughter ?

Acta gastro-enterologica belgica, 2012-06, Vol.75 (2), p.203-209

2012

Volltextzugriff (PDF)

Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B : Antiviral and immunological activity

Hepatology (Baltimore, Md.), 2005-11, Vol.42 (5), p.1028-1036

2005

Volltextzugriff (PDF)

Ceramides in Autoimmune Rheumatic Diseases: Existing Evidence and Therapeutic Considerations for Diet as an Anticeramide Treatment

Nutrients, 2023-01, Vol.15 (1), p.229

2023

Volltextzugriff (PDF)

Multiple Viral/Self Immunological Cross-Reactivity in Liver Kidney Microsomal Antibody Positive Hepatitis C Virus-Infected Patients is Associated with the Possession of HLA B51

International journal of immunopathology and pharmacology, 2004-01, Vol.17 (1), p.83-92

2004

Volltextzugriff (PDF)

Hepatitis E virus antibodies in hemodialysis patients: an epidemiological survey in central Greece

International journal of artificial organs, 2004-10, Vol.27 (10), p.842-847

2004

Volltextzugriff (PDF)

Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse nonviral hepatic diseases

Journal of viral hepatitis, 2004-07, Vol.11 (4), p.358-365

2004

Volltextzugriff (PDF)

DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long-term therapy before HBsAg loss in non-cirrhotic HBeAg-negative chronic hepatitis B

Antiviral therapy, 2018-01, Vol.23 (8), p.677-685

2018

Volltextzugriff (PDF)

Disease-specific cross-reactivity between mimicking peptides of heat shock protein of mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis

Journal of autoimmunity, 2004-06, Vol.22 (4), p.353-362

2004

Volltextzugriff (PDF)

HCV-RNA qualitative assay based on transcription mediated amplification improves the detection of hepatitis C virus infection in patients on hemodialysis: Results from five hemodialysis units in central Greece

Journal of clinical virology, 2005-09, Vol.34 (1), p.81-85

2005

Volltextzugriff (PDF)

PS-043 - DARING-B: discontinuation of effective entecavir or tenofovir therapy in non-cirrhotic HBeAg-negative chronic hepatitis B patients: a prospective Greek study

Journal of hepatology, 2017, Vol.66 (1), p.S26-S26

2017

Volltextzugriff (PDF)

Anti-sp100 antibodies in primary biliary cirrhosis

Scandinavian journal of gastroenterology, 2004-04, Vol.39 (4), p.406-407

2004

Volltextzugriff (PDF)

PS-159 - Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in noncirrhotic HBeAg-negative chronic hepatitis B patients: Results from the DARING-B prospective Greek study

Journal of hepatology, 2018-04, Vol.68, p.S88-S89

2018

Volltextzugriff (PDF)

Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in noncirrhotic HBeAg-negative chronic hepatitis B patients: Results from the DARING-B prospective Greek study

Journal of hepatology, 2018-04, Vol.68, p.S88-S89

2018

Volltextzugriff (PDF)

Autoimmune hepatitis type 1 and primary biliary cirrhosis have distinct bone marrow cytokine production

Journal of autoimmunity, 2005-12, Vol.25 (4), p.283-288

2005

Volltextzugriff (PDF)

Hepatobiliary malignancy surveillance strategies in primary sclerosing cholangitis associate with reduced mortality

JOURNAL OF HEPATOLOGY, 2021, Vol.75 (Suppl. 2), p.S227

2021

Volltextzugriff (PDF)

Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis

Journal of hepatology, 2004, Vol.40 (1), p.31-39

2004

Volltextzugriff (PDF)

1 – 25 von 269

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(257)
Mit Volltextzugriff
(261)

Publikationsform

Sprache

Englisch
(261)
Japanisch
(44)
Spanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A real‐world study focused on the long‐term efficacy of mycophenolate mofetil as first‐line treatment of autoimmune hepatitis

Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis

Infectomics and autoinfectomics: a tool to study infectious-induced autoimmunity

DARING-B: discontinuation of effective entecavir or tenofovir therapy in non-cirrhotic HBeAg-negative chronic hepatitis B patients: a prospective Greek study

Blocking of interleukin-10 receptor—a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus

Peculiar antibody reactivity to human connexin 37 and its microbial mimics in patients with Crohn's disease

Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection

Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients

Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus

Familial primary biliary cirrhosis: Like mother, like daughter ?

Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B : Antiviral and immunological activity

Ceramides in Autoimmune Rheumatic Diseases: Existing Evidence and Therapeutic Considerations for Diet as an Anticeramide Treatment

Multiple Viral/Self Immunological Cross-Reactivity in Liver Kidney Microsomal Antibody Positive Hepatitis C Virus-Infected Patients is Associated with the Possession of HLA B51

Hepatitis E virus antibodies in hemodialysis patients: an epidemiological survey in central Greece

Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse nonviral hepatic diseases

DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long-term therapy before HBsAg loss in non-cirrhotic HBeAg-negative chronic hepatitis B

Disease-specific cross-reactivity between mimicking peptides of heat shock protein of mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis

HCV-RNA qualitative assay based on transcription mediated amplification improves the detection of hepatitis C virus infection in patients on hemodialysis: Results from five hemodialysis units in central Greece

PS-043 - DARING-B: discontinuation of effective entecavir or tenofovir therapy in non-cirrhotic HBeAg-negative chronic hepatitis B patients: a prospective Greek study

Anti-sp100 antibodies in primary biliary cirrhosis

PS-159 - Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in noncirrhotic HBeAg-negative chronic hepatitis B patients: Results from the DARING-B prospective Greek study

Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in noncirrhotic HBeAg-negative chronic hepatitis B patients: Results from the DARING-B prospective Greek study

Autoimmune hepatitis type 1 and primary biliary cirrhosis have distinct bone marrow cytokine production

Hepatobiliary malignancy surveillance strategies in primary sclerosing cholangitis associate with reduced mortality

Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis

Suchergebnisse filtern